Association of Generic Competition With Price Decreases in Physician-Administered Drugs and Estimated Price Decreases for Biosimilar Competition
Author:
Affiliation:
1. West Health Policy Center, Washington, DC
2. West Health Institute, La Jolla, California
Publisher
American Medical Association (AMA)
Subject
General Medicine
Link
https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2786133/dickson_2021_oi_210949_1636051211.13559.pdf
Reference25 articles.
1. Revisions to payment policies under the physician fee schedule and other revisions to Part B for CY 2018; Medicare shared savings program requirements; and Medicare diabetes prevention program, CMS-1676-F.;Centers for Medicare & Medicaid Services;Fed Regist,2017
2. Uptake of infliximab biosimilars among the Medicare population.;Chen;JAMA Intern Med,2020
3. Uptake of the biologic filgrastim and its biosimilar product among the Medicare population.;Kozlowski;JAMA,2018
4. Physician, practice, and patient characteristics associated with biosimilar use in Medicare recipients.;Dean;JAMA Netw Open,2021
5. Biosimilar uptake in Medicare Part B varied across hospital outpatient departments and physician practices: the case of filgrastim.;Socal;Value Health,2020
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Patterns of Infliximab Biosimilar Uptake for Medicare, Medicaid, and Private Insurance from 2016 to 2022;Arthritis & Rheumatology;2024-08-13
2. Enhancing Taiwan's healthcare sustainability: A Delphi study on national medicines policy reforms;Journal of the Formosan Medical Association;2024-08
3. Anti-TNFα in inflammatory bowel disease: from originators to biosimilars;Frontiers in Pharmacology;2024-07-24
4. Challenges of Incorporating Life Cycle Drug Pricing in Cost-Effectiveness Models: A Review of Methods and Modeling Suggestions;Value in Health;2024-07
5. Reduction of biologic pricing following biosimilar introduction: Analysis across 57 countries and regions, 2012–19;PLOS ONE;2024-06-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3